Year: 2023
Type: other
Abstract: In Memoriam I t is with the deepest sorrow that we report that Joseph Biederman, MD, died on January 5, 2023, after his battle with cancer.Simply stated, Joe was a true legend.His research work, carried out over more than 4 decades, propelled forward the study of ADHD and the field of Child Psychiatry.He was regarded as the father of pediatric psychopharmacology and demonstrated tireless dedication to the examination of the causes, diagnosis, and treatment of ADHD across the lifespan.His work has been internationally recognized, accepted, and integrated into the practice of medicine.He was one of the most cited psychiatrists and child psychiatrists in all of medicine and one of the most productive researchers at Harvard Medical School.If all he did was research, that would have been enough for an impactful legacy.But Joe was so much more than just a researcher.Joe was a mentor to several generations of faculty, both at Massachusetts General Hospital (MGH) and at other institutions.He worked closely with junior clinical investigators who now themselves mentor the next generation of clinician scientists.The MGH Division of Child Psychiatry is a testament to Joe's decades-long inspirational leadership, during which, at every turn, he guided the fulfillment of our faculty's collective work.Joe was a master clinician to whom colleagues and friends would send their most severely ill children knowing he would apply his vast clinical wisdom to help craft a path to better emotional well-being for a young person in need.In addition to his exceptional competence as a psychopharmacologist, he was highly regarded as an empathic physician who was beloved by his patients and their families.He never steered from the clinical care of children with serious mental illness.He derived great joy from the
DOI: 10.4088/jcp.23f14803
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4321180391